# Oshi Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/oshi-health

- Industry: Healthcare IT
- Headquarters: New York, US
- Website: www.oshihealth.com
- Total disclosed funding: $112M
- Latest round: Series C (Oct 16, 2024)
- Investors on record: 11

## About

Based in New York, US, and founded in 2018 by co-founders John Allen and Gil Y. Melmed, Oshi Health, Inc. operates as a provider of a virtual health platform that monitors and treats patients with the digestive health condition. In October 2024, Oshi Health, Inc. raised USD 60 million in series C funding led by new investor Oak HC/FT Partners, with participation from returning investors Takeda Ventures, CVS Health Ventures, Frist Cressey Ventures, Flare Capital Partners, and Bessemer Venture Partners.

Oshi Health, Inc. developed a mobile application platform, that specializes in a virtual-first gastrointestinal (GI) care clinic that provides personalized and medical care for people living with GI conditions. It integrates evidence-based medical care with behavioral health support into an insight-based care model. The company offers a variety of services for GI symptoms and conditions, including acid reflux, GERD, bloating, abdominal pain, nausea, Crohn's disease, ulcerative colitis, irritable bowel syndrome (IBS), and many more. Its focuses on offering virtual visits for patients to access care from their homes. 

The company will use the funding to add partnerships with more provider groups, grow payer coverage, service new employer partners, and expand into medicare populations starting in 2025.

## Funding rounds

- Series C, Oct 16, 2024, $60M — Bessemer Venture Partners, Takeda Ventures, Oak HC/FT, Frist Cressey Ventures, Flare Capital Partners, CVS Health Ventures, American Gastroenterological Association, American College of Gastroenterology, Inc.
- Series B, Mar 23, 2023, $30M — Bessemer Venture Partners, Takeda Ventures, Frist Cressey Ventures, Flare Capital Partners, Koch Disruptive Technologies, Varia Ventures, CVS Health Ventures
- Series A, Sep 21, 2021, $22M — Bessemer Venture Partners, Takeda Ventures, Frist Cressey Ventures, Flare Capital Partners, Operator Partners, CVS Health Ventures

## Investors

- Bessemer Venture Partners (https://capitalatlas.ai/funds/bessemer-venture-partners) — Series A, Series B, Series C
- Takeda Ventures (https://capitalatlas.ai/funds/takeda-ventures) — Series A, Series B, Series C
- Frist Cressey Ventures (https://capitalatlas.ai/funds/frist-cressey-ventures) — Series A, Series B, Series C
- Flare Capital Partners (https://capitalatlas.ai/funds/flare-capital-partners) — Series A, Series B, Series C
- Operator Partners — Series A
- CVS Health Ventures (https://capitalatlas.ai/funds/cvs-health-ventures) — Series A, Series B, Series C
- Koch Disruptive Technologies (https://capitalatlas.ai/funds/koch-disruptive-technologies) — Series B
- Varia Ventures (https://capitalatlas.ai/funds/varia-ventures) — Series B
- Oak HC/FT (https://capitalatlas.ai/funds/oak-hc-ft) — Series C
- American Gastroenterological Association — Series C
- American College of Gastroenterology, Inc. — Series C